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Abstract 
Background: We aim to demonstrate behavioral alterations in a sepsis model using intravenous (IV) immunoglobu-
lin G (IgG) and immunoglobulins enriched with IgA and IgM (IgGAM).
Methods: We divided 48 Wistar albino rats into five groups: control group, sham-operated group (only antibiotic 
treatment), cecal ligation and puncture (CLP) group (CLP plus antibiotic treatment), IgG group (250 mg/kg IV IgG) 
and IgGAM group (250 mg/kg IV IgGAM). Intravenous immunoglobulins were given 5 min after the CLP procedure. 
Experimental animals put into three behavioral tasks 10, 30 and 60 days after the surgery; to evaluate the locomotor 
activity, an open field test was performed, elevated plus maze test was used to measure anxiety levels, and depres-
sive state was assessed by forced swimming test. The effects of therapy which were acquired from the results of these 
tests were used to estimate the behavioral changes after CLP.
Results: The mortality rate of 50% in the septic rats decreased to 30 and 20% with the administration of IgG and 
IgGAM, respectively. Significant changes on locomotor activity and depressive-like behavior were reported in the 
sepsis group; on the other hand, the treatment with immunoglobulins reduced the symptoms. Treatment with immu-
noglobulins attenuated the sepsis-related anxiogenic-like responses. Behavioral alterations returned to normal on day 
60 in all groups.
Conclusions: Sepsis caused deterioration on behavioral parameters. Immunoglobulin treatments alleviated the 
symptoms of functional disturbances and caused early reversal of behavioral deficits in septic animals.
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Background
Acute brain dysfunction is a common complication of 
sepsis, which has been reported to be associated with 
adverse outcomes like long-term cognitive impairments. 
Although the underlying mechanism remains poorly 
understood, inflammation causing cerebral endothe-
lial activation and blood–brain barrier (BBB) alterations 
were reported in several models of septic brain [1, 2]. 
Cognitive consequences of sepsis were tested in septic 
rats in which survivors showed learning and memory 
impairment after complete physical recovery in a CLP 
model [3]. Other experimental studies also suggested this 
model as a clinically relevant method to investigate cog-
nitive impairment in sepsis survivors [4, 5]. Treatments 
targeted to manipulate the inflammatory pathways have 
been investigated to influence long-term cognitive defi-
cits in sepsis-induced brain dysfunction. Various thera-
peutic interventions have been tested in experimental 
trials. The beneficial effects of antioxidant treatment in 
long-term memory impairment were reported in a cecal 
ligation and puncture (CLP) model in rats [4]. Ritter et al. 
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showed antioxidant treatment with N-acetylcysteine and 
deferoxamine prevents cognitive impairment in septic 
mice [6]. Guanosine treatment was reported to reduce 
oxidative stress and recovered the impaired memory in 
CLP-induced septic rats [7]. Administration of epineph-
rine, naloxone, dexamethasone and glucose in septic sur-
vivors reversed long- term cognitive impairment [8]. We 
recently demonstrated that treatment with intravenous 
immunoglobulin protects the BBB integrity and inhibits 
CLP-induced sickness behavior, and improves survival in 
septic animals [9].
In this study, we want to investigate the time-depend-
ent protective effects of a single dose of standard Immu-
noglobulin G (IgG) and immunoglobulin’s enriched with 
IgA and IgM (IgGAM) intravenous (IV) administration 
on long-term behavioral alterations including depression 




We used male Wistar Albino rats (200–250  g). Animals 
were obtained from Marmara University, Istanbul. Ani-
mals were kept in groups under normal conditions (tem-
perature 22  ±  1°C, humidity 55  ±  5%) with access to 
food and water ad  libitum. The procedures of the study 
were approved by the Local Ethics Committee for Ani-
mal Experimentation (78/2012 March). Experimental 
groups were assigned as control (n =  6), sham (n =  6), 
CLP (n =  12), IgG (n =  12) and IgGAM (n =  12). The 
total sample of 48 subjects achieves 93% power to detect 
a non-zero contrast of the means versus the alternative 
that the contrast is zero using an F test with a 0.050 sig-
nificance level. The value of the contrast of the means is 
−12.00. The common standard deviation within a group 
is assumed to be 3.00. Random number table has been 
used for selection of subject. The randomization was 
done using online software (http://www.randomization.
it) to generate a random allocation sequence. Flowchart 
is shown in Fig. 1.
Cecal ligation and puncture procedure
Cecal ligation and puncture procedure was performed 
as explained by Rittirsch et al. [10]. Animals were intra-
peritoneally anesthetized with ketamine (100  mg/kg). 
Rats were placed in a supine position and the abdomi-
nal area was shaved. The area was disinfected with alco-
hol; an incision was made in abdominal wall. The cecum 
was isolated with anatomical forceps and mesenteric 
blood vessels were carefully taken care of to prevent dis-
section. Sepsis was induced with cecal ligation and two 
punctures were made with an 18-gauge needle through 
the cecum. A small amount of feces was extruded after 
removing the needle, and the cecum was replaced into 
the abdominal cavity. The animals were then treated with 
pre-warmed saline (37°C; 5  mL per 100  g body weight) 
Fig. 1 Flowchart of experiment. CLP Cecal Ligation Perforation.
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subcutaneously, and then moved back into their cages. 
Sham-operated rats underwent the same procedure, 
without ligation and puncture of the cecum. After the 
procedure, antibiotic treatment, clindamycin (150  mg/
kg) and ceftriaxone (50  mg/kg) were given intraperito-
neally every 6 h for a total 3 days.
Administration of immunoglobulins
The animals were given human IgG; 250  mg/kg (Octa-
pharma; Vienna, Austria) or IgGAM, 250  mg/kg 
(Pentaglobin; Biotest, Dreieich, Germany) intravenously 
via penile vein 5 min after CLP procedure. After the IV 
injection, the animals were placed back to their cages for 
recovery. Three behavioral tasks were applied to all ani-
mals 10, 30 and 60 days after the surgery.
Behavioral procedures
Open field test
With open field test (OFT), we tried to evaluate the 
behavior and function in terms of both locomotor activ-
ity and daily habits. The OFT was performed on the 10th, 
30th and 60th days. In brief, the open field apparatus 
consists of a rectangular area of 80 × 60 cm surrounded 
by a 30-cm-high wall. It was divided into 35 equal sized 
squares with white lines on the floor. A single rat was 
placed in the center of the area and observed for 5 min. 
The number of center squares passed, total squares 
passed, time spent in the center squares, time spent in 
the four corner squares, numbers of rearing and groom-
ing events, and the number of defecations were recorded. 
The apparatus was thoroughly cleaned using 70% alcohol 
after each testing period. The scores were computed for 
further statistical analysis [11].
Elevated plus maze
The elevated plus maze (EPM) was performed on the 
10th, 30th and 60th days. The EPM apparatus consisted 
of two opposite open arms (42.5 cm × 14.5 cm), and two 
opposite arms of equal size enclosed by walls 30  cm in 
height, with open tops. The arms were connected by a 
central 10 × 10 cm square, giving the maze the shape of a 
plus sign. The maze was elevated 78.5 cm from the floor. 
All rats were placed individually in the center of the maze 
facing a closed arm and allowed 5  min of free explora-
tion. Entries and time spent in open and closed arms 
were measured. The EPM was thoroughly cleaned using 
70% ethanol after each rat. The scores were computed for 
further statistical analysis [12].
Forced swim test
The forced swim test (FST) was performed at the end of 
the study. It was conducted by placing all rats individually 
in the testing cylinders (45 cm high × 20 cm in diameter) 
filled with 30  cm water, maintained at 25  ±  1°C. The 
rats were allowed to swim in the cylinder under condi-
tions in which escape is impossible. In the first trial, 
rats were allowed to swim for 12  min. They were then 
removed from water, dried and put into a warmed place 
for approximately 15 min. After 24 h, the second trial was 
performed. This trial lasted 5  min and was recorded by 
a video camera. In this trial, we measured duration of 
immobility, which is explained as the absence of motion 
of the body except for small action necessary to keep the 
rat’s head above the water. After 5 min, rats were taken 
from the cylinder, dried and placed in a warmed place 
for approximately 15  min before returning to home 
cages. After the procedure, the devices were emptied and 
cleaned following every session [13].
Statistical analysis
Results from the tests are presented as mean  ±  SEM. 
Data were analyzed by one-way analysis of variance 
(ANOVA) followed by the Tukey’s multiple comparison 
test, using GraphPad Prism 5. Statistical significance was 
set as p < 0.05.
Results
Overall mortality rate found 50% in septic animals was 
dropped to 30 and 20% by IgG and IgGAM, respectively. 
The number of rats which behavioral tasks have been 
applied at 10th, 30th and 60th days’ time points were 6, 
4, 4 in CLP group, 11, 9, 9 in IgG group and 11, 10, 10 
in IgGAM group, respectively. The results of the behav-
ioral alterations caused by CLP-induced sepsis assessed 
by open field, elevated plus maze and forced swimming 
tasks are shown as follows:
Open field test
The number of crossed squares was not statistically dif-
ferent between sham and control groups. The values of 
OFT decreased in the CLP group compared with controls 
on day 10 and 30 (Fig. 2a; p < 0.01). When compared with 
the CLP group, the number of crossed squares increased 
on day 10 and 30 in the IgGAM group (p < 0.01, p < 0.05, 
respectively), whereas it increased only on day 10 in the 
IgG group (p < 0.01) but not on day 30. There was no sig-
nificant difference on day 60 among the groups (Fig. 2a). 
The number of rearing events reduced in the CLP group 
compared with control values on day 10 (p  <  0.01) but 
not on day 30 or 60 (Fig.  2b). Both immunoglobulin 
treatments were able to elevate the number of rearing 
events compared with CLP group only on day 10 (Fig. 2b, 
p  <  0.01). Overall, there was no statistically difference 
between control and sham groups.
With the exception of the IgGAM group who spent 
more time in the central zone than the CLP group on 
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day 10, there was no statistical difference in this param-
eter among all groups/measurements (Fig. 2c, p < 0.05). 
Grooming events significantly decreased in the CLP 
group compared with controls on day 10 (p  <  0.01), 30 
(p < 0.01) and 60 (Fig. 2d, p < 0.05). The IgGAM group 
showed higher grooming activity than the CLP group on 
day 10 and 30 (Fig. 2d, p < 0.05). The IgG group was not 
statistically different from CLP or other groups. Overall 
there was no statistical difference between the control 
and sham groups (Fig. 2d).
Elevated plus maze
Anxiety-like behavior is evaluated with EPM. Time spent 
on open arms was decreased in the CLP group when 
compared with controls on day 10 (p  <  0.01). IgG and 
IgGAM treatments increased the time spent on open 
arms compared with the CLP group on day 10 (Fig. 3a, 
p  <  0.05, p  <  0.01, respectively). There was no signifi-
cant difference in time spent on open arms between the 
groups on day 30 and 60 (Fig. 3a). The number of open 
and closed arms entries were significantly decreased 
in the CLP group compared with controls on day 10 
(Fig. 3b, c, p < 0.01 and p < 0.05, respectively), whereas 
both the IgG and IgGAM treatments showed a higher 
number of entries to open arms compared with the CLP 
group on day 10 (Fig.  3b, p  <  0.01). Closed arm entries 
were only higher in the IgG group when compared with 
the CLP group (Fig. 3c, p < 0.05) on day 10. All groups 
showed similar results on day 30 and 60 (Fig. 3b, c).
Forced swim test
Depressive-like behavior is evaluated with FST. The time 
of immobility was greater in the CLP group compared 
with the control group on day 10 (Fig.  4, p  <  0.01). On 
the other hand, both IgG and IgGAM treatments showed 
decreased immobility time compared with the CLP 
group on day 10 (Fig. 4, p < 0.01). There was no signifi-
cant difference in immobility time among the groups on 
day 30 and 60 (Fig. 4).
Discussion
The present study demonstrated that sepsis induced by 
CLP resulted in behavioral deficits in open field, elevated 
plus maze and forced swimming tasks 10 days after sur-
gery that mainly resolved within 30 days. The main find-
ing of the study is that treatment with immunoglobulin 
after sepsis induction caused earlier resolution in locomo-
tor function and behavioral alterations including depres-
sion and anxiety. All surviving animals presented nearly 
normal performance in all tests performed after 60 days 
indicating recovery of functional disturbances. The over-
all survival rate in the CLP group was 50% in accordance 
with other studies, whereas it was 70% after the standard 
IgG and 80% in the Ig GAM treatment groups.
Fig. 2 Open field test on days 10, 30 and 60. a Number of squares passed in OFT. b Number of total rearing movements in OFT. c Time spent on 
center squares in OFT. d Number of grooming bouts in OFT. Data are shown as mean ± SEM; *p < 0.01 compared to control, **p < 0.05 compared 
to control, †p < 0.01 compared to CLP, ††p < 0.05 compared to CLP. OFT open field test, CLP Cecal Ligation Perforation.
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Long-term cognitive impairment including alterations in 
memory, anxiety, depression and impairment in executive 
function was reported in sepsis survivors [14]. Each of these 
was shown to be associated with a decreased quality of life. 
CLP model was extensively used to address the mechanisms 
associated with cognitive deficits seen in sepsis and help to 
investigate therapeutic approaches for this problem [3, 15]. 
Among cognitive functions, memory was reported to be the 
most frequently observed deficit. The present study evalu-
ated the changes in locomotor activity, anxiety and depres-
sive-like symptoms in sepsis-surviving rats.
We studied three basic behavioral tasks that were 
mainly used in those experiments determining long-term 
effects in sepsis-surviving animals. Forced swimming 
test was used as a model for determining depressive-like 
behavior [13], elevated plus maze test was used for anxi-
ety measurement [12], and animals were put into differ-
ent open field facilities to determine the alterations in 
locomotor and functional activities [11]. Time-dependent 
measurements in CLP-induced septic animals were in 
accordance with previous reports in terms of decreases 
in locomotor activity and increases in depressive-like 
Fig. 3 Elevated plus maze test on days 10, 30 and 60. a Time spent on open arms in EPM test. b Number of entries to open arms in EPM test. c 
Number of entries to closed arms in EPM test. Data are shown as mean ± SEM; *p < 0.01 compared to control, **p < 0.05 compared to control, 
†p < 0.01 compared to CLP. ††p < 0.05 compared to CLP. EPM elevated plus maze; CLP, Cecal Ligation Perforation.
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behavior [8]. Rearing and grooming events dramatically 
decreased in animals in the CLP group, which indicated 
attenuation in the locomotor activity by the induction 
of sepsis. The activity was attenuated on day 10 and 30. 
These results were in contrast with the previous reports, 
which indicated no change in the locomotor and explora-
tory activities in the open field test in the CLP group 
compared with control group, 10  days after the proce-
dure [3, 8, 15–17]. Similar to these, Leite et al. found no 
significant effects of CLP on the locomotor activity in 
OFT 7 days after surgery compared with the sham group 
[18]. Overall, both immunoglobulin treatments were able 
to elevate the number of rearing and grooming events 
compared with the CLP group on day 10, whereas the 
IgGAM group was also able to increase grooming on day 
30. Although there was no difference in terms of the time 
spent in the central zone when the CLP group compared 
with the control group, the IgGAM group stays longer 
than CLP group in the central zone on day 10, which 
indicated a better reversal of anxiety-like behavior.
In the FST, the time of immobility, indicating a depres-
sive-like behavior, was higher in the CLP group compared 
with the control group on day 10, which is compatible 
with previous reports that used the CLP model. Two pre-
vious studies reported a significant increase in the immo-
bility time in the CLP group compared with the sham 
group, 10 days after CLP procedure [5, 15]. In addition, 
a recent study that used a sucrose consumption test as 
a depressive-like state model reported that CLP induc-
tion caused anhedonia with the reduced sucrose intake 
compared with the sham group, 17  days after surgery 
[17]. We found no differences in the time of immobil-
ity between the groups on day 30 and 60 meaning that 
depressive-like state was resolved before 30  days in 
the CLP group. In a previous study, the CLP group was 
shown to have increased immobility time compared 
with the sham group on day 10 and day 30, but not on 
day 60 [8]. We showed that both IgG and IgGAM treat-
ments decreased immobility time compared with the 
CLP group on day 10, which can be interpreted that both 
treatments reversed CLP-induced depressive-like behav-
iors by day 10.
The CLP procedure produced an anxiogenic-like 
effect 10  days after surgery. This was demonstrated by 
the decreased time spent in open and closed arms of the 
EPM task. This was not the case in the previous experi-
mental trials that studied long-term depression and anxi-
ety after sepsis. Two experimental trials demonstrated 
no change in the anxiety-like behavior after CLP [3, 5]. 
Most recently, Leite et al. demonstrated significant anxi-
ety in CLP-induced septic animals, which is in accordance 
with our findings [18]. In the present study, anxiety-like 
behavior had resolved in the CLP group by day 30 after 
surgery. Both immunoglobulin treatments increased the 
time spent in open arms, which was coupled with higher 
number of entries to open arms compared with the CLP 
group on day 10. Treatment with IgG and IgGAM caused 
early resolution of functional and behavioral alterations 
after sepsis induction, which indicated some treatment 
effect. This was parallel to the improved survival in the 
treatment groups. The underlying mechanisms of which 
immunoglobulin exerts these effects are most probably 
due to their regulatory involvement in the inflammatory 
processes causing endothelial activation and the break-
down of the BBB [19]. In our previous experimental trial, 
immunoglobulin treatment protected the brain from sep-
sis-induced effects [9]. Fewer morphologic changes and 
less disruption in BBB integrity were evident, which was 
in accordance with the improved survival in the treatment 
groups. The BBB failure in sepsis is explained by endothe-
lial cell injury through cytokines such as TNF-α and IL-β 
that leads to upregulation of endothelial surface antigens 
Fig. 4 Forced swimming test on days 10, 30 and 60. Immobility times in FST. Data are shown as mean ± SEM; *p < 0.01 compared to control, 
†p < 0.01 compared to CLP. FST forced swimming test, CLP Cecal Ligation Perforation.
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and subsequent white blood cells adherence as well as 
microcirculatory dysfunction [20]. Experimental studies 
have shown that IVIG is capable of significantly reducing 
leukocyte adhesion and by normalizing capillary perfu-
sion attenuate microcirculatory dysfunction [21]. Using 
intravital microscopy, the effects of immunoglobulins on 
leukocyte recruitment in superficial brain vessels were 
visualized. Immunoglobulins potentially reduced leuko-
cyte rolling and adhesion in experimental autoimmune 
encephalomyelitis (EAE) [22]. It has been suggested that 
immunoglobulins exert these actions either through their 
effects on cytokine production or directly by reducing 
cell adhesion molecule production [22, 23]. Experiments 
using cultures of bovine and human brain endothelium 
suggest that cytokines increase BBB permeability. TNF-α 
was stained on microvascular vessels of the brain in sepsis 
and recombinant TNF-α also increased the permeability 
in mice [20]. Studies demonstrated that immunoglobulins 
contain high-affinity neutralizing antibodies against IL-1 
IL-6 and TNF-α and downregulate their synthesis by their 
effects on T cells [21, 24].
The beneficial effects of IV immunoglobulins on the 
BBB are most probably due to their regulating effects on 
the complement system [25]. The neurotoxic effects of 
complement fragments have recently been studied and 
blocking C5a anaphylatoxin resulted in neuroprotective 
effects in CLP-induced septic animals [26]. Arumugam 
et  al. have demonstrated that complement activation in 
neuroinflammation was regulated with immunoglobulins 
in an experimental stroke model, and immunoglobulins 
reduced the mortality and the amount of brain damage 
[27].
In the current study, two different types of immuno-
globulin preparations were used expecting that IgM 
would improve functional and behavioral alteration 
caused by sepsis. Early experimental studies have dem-
onstrated superior effects of IgM in comparison with 
IgG in terms of their activities on inflammation [28, 29]. 
Both intravenous IgM and IgG preparations markedly 
attenuated the endotoxin-induced leukocyte adherence; 
however, only intravenous IgM was capable of further 
reducing venular leukocyte adherence, whereas IgG did 
not show protective effects compared with controls. This 
effect was also evident with the measurement of func-
tional capillary density (FCD) where IgM significantly 
ameliorated the LPS-induced decrease of FCD after 24 h 
of endotoxemia [21]. Protective effects of IgM on tis-
sue integrity were studied on lungs where significantly 
reduced alveolar damage was evident parallel with the 
histological evaluation [30]. This study showed a better 
survival rate with IgM-enriched immunoglobulin admin-
istration during sepsis; however, both immunoglobu-
lin preparations were able to reverse behavioral deficits 
within 10 days, which were resolved by 60 days after sur-
gery in all groups.
One limitation of the study might be considered as the 
possible cross-species binding differences since we used 
human IV immunoglobulin preparation in rats as rodents 
that are routinely used as a convenient first-line model 
for clinical evaluation of IVIG therapies. Studies on the 
mapping of the binding side on human immunoglobulins 
suggested that the Fc interactions are, in some respects, 
very similar across species [31]. Second, the timing of 
IVIG administration might be considered as too early as 
to extrapolate its impact for clinical effectiveness; how-
ever, similar timing of IVIG administration has been 
widely used in experimental studies testing the potential 
of therapeutic effects. Third, in our setup, we were not 
able to evaluate a memory deficit which was reported to 
be the most frequently observed deficit in humans.
Conclusions
In the present experimental study, we show that that 
intravenous immunoglobulins provide early behavioral 
and functional recovery following sepsis. Our data are 
the first to show a better resolution of effects with immu-
noglobulin in sepsis-induced behavioral alterations. Fur-
ther researches are necessary to see if our findings can be 
extrapolated to humans.
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